Gene therapy for Duchenne muscular dystrophy is a hot topic at a recent neuromuscular conference. Experts share their perspective on the latest data and the impact new therapies will have on patients with DMD.
This activity is supported by an independent medical educational grant from Sarepta Therapeutics, Inc.
コメント